Outcomes of Septal Myectomy beyond 65 Years, with and without Concomitant Procedures

Outcomes of Septal Myectomy beyond 65 Years, with and without Concomitant Procedures

Introduction and objectives: Septal myectomy remains the first septal reduction therapy for hypertrophic obstructive cardiomyopathy in young patients and those requiring concomitant procedures. Its role in advanced ages is questioned due to perceived increased risk. We assess the outcomes of surgica...

Full description

Bibliographic Details
Main Authors: Robert Pruna-Guillen, Daniel Pereda, Manuel Castellà, Elena Sandoval, Alessandro Affronti, Ana García-Álvarez, Juan Perdomo, Cristina Ibáñez, Paloma Jordà, Susanna Prat-González, Jorge Alcocer, Clemente Barriuso, Jaume Llopis, Eduard Quintana
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Journal of Clinical Medicine
Subjects:
hypertrophic obstructive cardiomyopathy
septal myectomy
mitral regurgitation
cardiomyopathy
Online Access:https://www.mdpi.com/2077-0383/10/16/3499

Similar Items

Similar Items